http://www.sciencemag.org/content/vol297/issue5582/news-summaries.shtml
Martin Enserink
For at least 3 months, no new patients will be enrolled in a large trial of hormone replacement therapy taking place in the United Kingdom, Australia, and New Zealand. The U.K. Medical Research Council, the trial's main sponsor, ordered the pause last week and decided to ask an international panel to recommend whether to continue the trial in the face of evidence that prompted termination of a similar U.S. study 3 weeks ago. However, women already enrolled will be asked to keep taking their pills.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.